Gas6 promotes oligodendrogenesis and myelination in the adult central nervous system and after lysolecithin-induced demyelination by Goudarzi, S. et al.
Original Article
Gas6 Promotes Oligodendrogenesis
and Myelination in the Adult
Central Nervous System and After
Lysolecithin-Induced Demyelination
Salman Goudarzi1, Andrea Rivera1, Arthur M. Butt1, and Sassan Hafizi1
Abstract
A key aim of therapy for multiple sclerosis (MS) is to promote the regeneration of oligodendrocytes and remyelination in the
central nervous system (CNS). The present study provides evidence that the vitamin K-dependent protein growth arrest
specific 6 (Gas6) promotes such repair in in vitro cultures of mouse optic nerve and cerebellum. We first determined
expression of Gas6 and TAM (Tyro3, Axl, Mer) receptors in the mouse CNS, with all three TAM receptors increasing in
expression through postnatal development, reaching maximal levels in the adult. Treatment of cultured mouse optic nerves
with Gas6 resulted in significant increases in oligodendrocyte numbers as well as expression of myelin basic protein (MBP).
Gas6 stimulation also resulted in activation of STAT3 in optic nerves as well as downregulation of multiple genes involved in
MS development, including matrix metalloproteinase-9 (MMP9), which may decrease the integrity of the blood–brain barrier
and is found upregulated in MS lesions. The cytoprotective effects of Gas6 were examined in in vitro mouse cerebellar slice
cultures, where lysolecithin was used to induce demyelination. Cotreatment of cerebellar slices with Gas6 significantly
attenuated demyelination as determined by MBP immunostaining, and Gas6 activated Tyro3 receptor through its phosphor-
ylation. In conclusion, these results demonstrate that Gas6/TAM signaling stimulates the generation of oligodendrocytes and
increased myelin production via Tyro3 receptor in the adult CNS, including repair after demyelinating injury. Furthermore,
the effects of Gas6 on STAT3 signaling and matrix MMP9 downregulation indicate potential glial cell repair and immunor-
egulatory roles for Gas6, indicating that Gas6-TAM signaling could be a potential therapeutic target in MS and other
neuropathologies.
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Introduction
Multiple sclerosis (MS) is an autoimmune disease of the
central nervous system (CNS) that involves destruction of
oligodendrocytes and of the myelin sheath they produce
around axons. MS features an inﬂammatory response
that causes gradual demyelination through formation of
plaques or lesions in the CNS white matter, leading to
disruption in nerve impulse transmission (Saxena et al.,
2011). Remyelination occurs in MS by the recruitment of
oligodendrocyte progenitor cells (OPCs) to the lesion site
and their subsequent diﬀerentiation into myelinating
oligodendrocytes, under the control of multiple extracel-
lular and axon-derived factors (Wolswijk, 2002).
However, remyelination by OPCs ultimately fails, due
in part to their diﬀerentiation being suppressed by inhibi-
tory factors and the lack of a supportive cellular envir-
onment (Franklin, 2002; Kuhlmann et al., 2008). Hence,
there is a need for a greater understanding of the factors
regulating OPC diﬀerentiation and the development of
novel targets for promoting remyelination.
Growth arrest speciﬁc 6 (Gas6) is a vitamin K-depen-
dent protein that is a ligand for the TAM (Tyro3, Axl,
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Mer) family of receptor tyrosine kinases (RTKs). The
Gas6–TAM interaction is involved in a number of cellu-
lar processes including regulating cell survival, the
immune system, inﬂammation, proliferation, migration,
and removal of apoptotic cells and debris (Lu and
Lemke, 2001; Haﬁzi and Dahlba¨ck, 2006a; Weinger
et al., 2011), all of which are processes involved in MS.
The TAMs appear to play a signiﬁcant role in immune
system regulation and macrophage activation, as TAM
triple knockout mice feature a severe lymphoproliferative
disorder accompanied by broad-spectrum autoimmunity
(Lu and Lemke, 2001; Lemke and Lu, 2003). Gas6-TAM
signaling also plays a role in oligodendrocyte survival
(Shankar et al., 2003) and has been shown to enhance
remyelination in a cuprizone-induced demyelination
model (Binder et al., 2011). These observations together
implicate Gas6 as a natural molecule with potential thera-
peutic properties in MS, through its ability to promote
oligodendrocyte survival and maturation, concomitant to
its suppression of the innate immune response. In the
present study, we characterize the expression of TAM
receptors in the mouse CNS and demonstrate that Gas6
promotes oligodendrogenesis directly via Tyro3 receptor,




C57/BL6 mice aged postnatal day 7 (P7), P14, and adults
were used for developmental studies, and 2-month-old
adults were used for ex vivo experiments utilizing optic
nerves and organotypic cerebellar slices cultures. Also, a
transgenic mouse line was used in which green ﬂuorescent
protein (GFP) was expressed under control of the SOX10
gene promoter (Stolt et al., 2006; Azim and Butt, 2011).
All experiments involving animals were approved by
University of Portsmouth Ethics Committee and also
by the Home Oﬃce Animals Scientiﬁc Procedures Act
(1986). Animals were killed humanely by cervical disloca-
tion, and brains were removed rapidly and placed in ice-
cold saline or ﬁxative prior to experiments.
Real-Time Quantitative PCR
Total RNA was isolated from human oligodendrocyte
precursor cells (HOPC; 1600; ScienCell, CA), human
astrocyte-cerebellar (HA-c; 1810; ScienCell), cultured
optic nerves, and cortex and cerebellum of mice at diﬀer-
ent ages (P7, P14, and adult) using GeneJET RNA puri-
ﬁcation kit (Thermo Scientiﬁc, Loughborough, UK). The
RNA was reverse transcribed into ﬁrst-strand cDNA
(NanoScript RT kit, Primerdesign, Southampton, UK)
prior to use in real-time quantitative polymerase chain
reaction (qPCR) analysis. Samples from human cell
lines and from cortex and cerebellum of diﬀerent ages
were used to quantify gene expression, using speciﬁc pri-
mers and probes (Integrated DNA Technologies, IDT;
Leuven, Belgium; Supplementary Table 1) and a qPCR
master mix (FastStart Essential DNA Probes Master;
Roche, Burgess Hill, UK). Also, cDNA from cultured
optic nerves was analyzed for expression of 84 MS-
related genes in a qPCR mini-array format (RT2
ProﬁlerTM PCR Array Mouse Multiple Sclerosis;
PAMM-125Z; Qiagen, Hilden, Germany). The human
and mouse samples were normalized to GAPDH and
Cdc40 as respective housekeeping genes for each species.
The Cdc40 gene was selected based on our own prelim-
inary study of 12 reference genes (geNorm; Primerdesign
Ltd), which revealed Cdc40 to be among the most stable
of mouse reference genes (not shown). The qPCR data
from various mouse CNS tissues were analyzed based on
the relative standard curve method as described earlier
(Vouri et al., 2015). The qPCR ampliﬁcation data from
human samples and from optic nerves used in qPCR
mini-array were analyzed based on the 2Ct method,
where Ct is CtTarget gene – Cthousekeeping gene and Ct is
CtGas6 – CtMock, and 2
Ct shows the fold up- or
downregulation, where values >1 are upregulated and <1
are downregulated (Livak and Schmittgen, 2001). The
qPCR mouse mini-array contained 84 diﬀerent genes
involved in diﬀerent aspects of MS, including myelin-
ation, T-cell activation and signaling, adaptive immunity,
inﬂammation, and apoptosis (listed in Supplementary
Table 2).
Western Blot
Total protein extracts were obtained from fresh brain
regions from mice at P7, P14, and adult ages, as well as
from cultured optic nerves, using lysis buﬀer composed of
50mM Tris-HCl, 150mM NaCl, 1% Triton X-100, 0.5%
NP-40, 1mM EDTA, 10mM Na4P2O7, pH 8.0. The
extracts were loaded in equal total protein amounts on
a 10% SDS-polyacrylamide gel, and proteins were sepa-
rated by electrophoresis as described earlier (Goudarzi
et al., 2013). Separated proteins were then transferred
to a polyvinylidene ﬂuoride membrane (Immobilon-P;
Millipore, Watford, UK). Membranes were ﬁrst blocked
in 3% nonfat dry milk (for normal antibodies) or 3%
bovine serum albumin (for phospho-speciﬁc antibodies)
in 25mM Tris, 150mM NaCl, 0.05% Tween-20, pH 8.0,
for 1 h at room temperature (RT), after which they were
incubated at 4C overnight with primary antibodies. The
primary antibodies and their dilutions were as follows:
anti-Tyro3 (1:500, C-20), anti-Axl (1:500, C-20), anti-
GAPDH (1:500, V-18; Santa Cruz Biotechnology,
Santa Cruz, CA), anti-actin (1:10000, A2066; Sigma-
Aldrich, Poole, UK), anti-phospho-STAT3 (1:500; Cell
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Signaling Technology, Leiden, The Netherlands), anti-
phospho-Tyro3 (‘‘anti-phospho-MER/SKY’’; 1:1000,
Phospho-Tyr749/681; Abbexa, Cambridge, UK), and
anti-myelin basic protein (MBP, 1:500, MAB386;
Millipore, Darmstadt, Germany). Postincubation wash-
ing of the membrane (25mM Tris-HCl, 150mM NaCl,
0.05% Tween-20, pH 8.0) was followed by 1 h incubation
with a horseradish peroxidase-conjugated secondary anti-
body (1:5000; Promega, Madison, USA; Dako,
Denmark) at RT. Chemiluminescence detection reagent
(Luminata Forte Western HRP Substrate, Millipore) was
used to generate the signal, and bands were visualized
using a CCD-based digital gel imaging system (Bio-Rad
ChemiDocTM MP Imaging System, Hemel Hempstead,
UK). The intensity of each band was quantiﬁed by densi-
tometry using ImageJ software (Schneider et al., 2012),
and query protein band intensities were normalized
against those of GAPDH or actin protein in each sample.
Optic Nerve Culture
Mouse optic nerves were isolated and established in cul-
ture for several days as described earlier (Azim and Butt,
2011). Brieﬂy, 2-month-old transgenic Sox10-GFP or
wild-type mice were killed by cervical dislocation, and
optic nerves were removed while still attached to the eye-
ball and immediately placed in ice-cold artiﬁcial cerebro-
spinal ﬂuid. The tissue was placed onto semiporous
membrane inserts (0.4 mm; Millipore) and covered with
2ml culture medium containing 50% Opti-MEMTM,
25% horse serum, 25% Hanks Balanced Salt Solution
(Gibco Invitrogen, Paisley, UK), supplemented with
25mM D-glucose (Sigma), and antibiotics (Penicillin G
sodium 10,000U/ml, streptomycin sulfate 1,000 mg/ml;
Gibco Invitrogen) diluted to 1:500, in a six-well culture
plate. For experiments, recombinant Gas6 protein
(diluted in cell culture medium containing Dulbecco’s
Modiﬁed Eagle Medium, supplemented with 10% fetal
calf serum, 100U/ml penicillin, 100 mg/ml streptomycin,
and 2mM L-glutamine; Lonza, Slough, UK) was added
directly to the culture medium at 400 ng/ml ﬁnal concen-
tration. In some experiments, Gas6 or Axl inhibitors were
added, including the Gas6 antagonists soluble Axl/Fc as
ligand quencher (R&D Systems, Minneapolis, MN) and
warfarin-Gas6 (produced in-house) (both previously used
by us and not toxic; Stenhoﬀ et al., 2004), and the Axl-
speciﬁc small molecule inhibitor BGB324 (Stratech
Scientiﬁc, Newmarket, UK), which was used at a concen-
tration of 1 mM as previously reported by us as eﬀective in
culture (Vouri et al., 2015). The cultures were incubated
for 3 days, or for 3 h in signaling activation experiments.
Cell culture medium alone was used as mock treatment,
the same as the medium containing recombinant Gas6, as
described earlier (Vouri et al., 2015). The culture medium
and treatments were replenished on the second day of
incubation. After 3 days, optic nerves were detached
from the eye and the tissue processed for either Western
blotting or qPCR, and samples from transgenic Sox10-
GFP mice were ﬁxed (4% paraformaldehyde, 15%
picric acid) for 1 h at RT, prior to whole mounting on
slides in mounting medium (Vectashield; Vector Labs,
Peterborough, UK) and confocal microscopic examination
of Sox10þ cells. All experiments were repeated with cul-
tures prepared from diﬀerent animals at diﬀerent times.
Organotypic Cerebellar Slice Culture
Sagittal sections of 300 mm thickness were made from
brains of C56/BL6 mice at ages P8 to P12, using a
tissue chopper (Campden Instruments, Loughborough,
UK). The sections were placed onto semiporous mem-
brane inserts (0.4 mm; Millipore) and covered with 1ml
culture medium composed of 50% Minimum Essential
Medium with Glutamax-1, 18% Earle’s Balanced Salt
Solution (EBSS), 5% EBSSþD-glucose, 1% penicillin-
streptomycin, and 10% horse serum (Gibco Invitrogen;
De Simoni and Yu, 2006). The slices were maintained on
0.4mm semiporous membrane inserts in a six-well plate at
37C in a humidiﬁed atmosphere with 5% CO2, for a
total of 7 days. After 3 days in culture, the slices were
either treated with Gas6 for 3 h to investigate signaling
mechanisms or in separate experiments to induce demye-
lination; on Day 3 of incubation, the medium was
replaced with fresh media containing 1mg/ml lysopho-
sphatidylcholine (LPC, lysolecithin; Sigma) or methanol
as vehicle. To investigate the eﬀect of Gas6 on demyelin-
ation, 400 ng/ml of recombinant Gas6 in conditioned cul-
ture medium and mock medium as control were added to
the same wells as the LPC treatments. All treatments with
LPC were incubated further for 24 h, following which the
medium was removed and the slices were incubated for
another 3 days in fresh medium in the presence of freshly
added Gas6 or mock treatments. Symmetrical cerebellar
sections were used for direct comparisons between mock
and Gas6 treatments. MBP immunoﬂuorescent staining
was then performed on the sections and analyzed by con-
focal microscopy. For quantiﬁcation of myelination, the
numbers of complete myelinated axons of length greater
than 50 mm were counted for each treatment using ImageJ
software. The values were converted to percentages and
normalized against the values for vehicle-treated sections.
Immunofluorescence Confocal Microscopy
Cell counts of Sox10-GFP-positive oligodendrocytes or
OPCs in optic nerves were performed on images taken
with a laser scanning confocal microscope (Zeiss LSM
710, Cambridge, UK). z-stack images were taken from
each optic nerve with dimensions of 212.34 212.34 mm
in the x- and y-plane and 70 mm in the z-plane at 10 mm
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intervals. The values of cell counts represent the mean
(SEM) percentage (%) of cells per ﬁeld of view.
Cerebellar sections were ﬁxed in 4% paraformalde-
hyde overnight, then blocked for 1 h in 20% normal
horse serum diluted in TBS-TX (41.9mM, Tris HCl;
8mM Tris base; 154mM NaCl; and 4.6mM Triton-X).
The sections were then incubated overnight with primary
antibodies diluted in TBS-TX at the following dilutions:
anti-MBP (1:300, MAB386; Millipore), anti-APC
(5ug/ml, Ab-7; Millipore), anti-NeuN (1:250, MAB377;
Millipore), and anti-glial ﬁbrillary acidic protein (GFAP,
1:400, AB5541; Millipore). The next day, after washing
with TBS-TX, the slices were incubated with the second-
ary antibodies for 2 h.
Statistical Analysis
All statistical analyses were performed using the software
IBM SPSS Statistics 20 or Prism 6 (GraphPad Inc, La
Jolla, CA). Animals were randomly assigned to treatment
groups. All results are expressed as meanSEM, with
each experiment performed a minimum 3 times unless
otherwise stated in the ﬁgure legend, using multiple rep-
licates per treatments. Diﬀerences between multiple treat-
ments in optic nerve cultures and organotypic cerebellar
slice culture were compared using one-way analysis of
variance followed by Bonferroni post hoc test, and com-
parison between two groups was carried out using
unpaired Student t test. A p value of less than .05 was
considered to be statistically signiﬁcant.
Results
Expression of Gas6 and TAM Receptors
in the Mouse CNS and in Human Glial Cells
TAM receptors are expressed in a wide variety of tissues
and organs throughout the body and, while it is indicated
that Tyro3 might be the main receptor in the CNS (Pierce
and Keating, 2014), the expression proﬁle of TAMs and
Gas6 in the CNS remains unclear. To obtain a comprehen-
sive picture of the whole TAMRTK subfamily and Gas6 in
the mouse CNS, qPCR was performed on mRNA from
diﬀerent regions of the CNS and at diﬀerent ages of post-
natal development. TAM and Gas6 mRNA expression
were detected in cortex and cerebellum of P7, P14, and
adult mice and in adult optic nerve (Figure 1(a)).
Furthermore, mRNA expression of all three TAMs
increased signiﬁcantly with age in the cortex but not in
the cerebellum. This qPCR expression data are valid only
for comparisons between samples per gene and not between
samples for diﬀerent genes. This is because the primer or
probe sets for diﬀerent genes will not have the same amp-
liﬁcation dynamics and so the arbitrary relative expression
values are valid only for a sample set for each gene.
In addition, Western blots showed clear expression of
both Axl and Tyro3 proteins in all mouse brain regions
and at all ages (Figure 1(b)), as well as in the adult optic
nerve. However, Tyro3 protein expression was signiﬁ-
cantly higher in cortex versus cerebellum in P14 and
adult, while the opposite was true of Axl expression
(Figure 1(b)). The two bands seen in Axl Western blots
are 120 kDa and 140 kDa forms of Axl due to diﬀer-
ent levels of glycosylation, reﬂecting diﬀerent levels of
maturation of the RTK.
The mRNA expression of Gas6, Tyro3, and Axl was
also analyzed by qPCR in cultured HOPCs and HA-c,
using the 2Ct method where Ct is Cttarget gene
Ctinternal control and 2Ct is the relative gene expression
(Schmittgen and Livak, 2008). Tyro3 was expressed
clearly in HOPC, whereas Axl was absent in this type
of glial cells. In stark contrast, Gas6 was highly expressed
in HA-c, while it was absent in HOPC (Figure 2).
Gas6 Promotes Oligodendrogenesis
in the Mouse Optic Nerve
To assess the eﬀect of Gas6 on oligodendrogenesis, we
used the optic nerve from adult Sox10-EGFP reporter
mice, in which the reporter is expressed by myelinating
oligodendrocytes, which make up the bulk of glia in the
optic nerve, together with adult OPCs, which make up
3% to 5% of cells in the adult optic nerve (Butt et al.,
2004). Optic nerves were isolated with retina intact and
maintained in organotypic culture for 3 days, in control
medium or medium containing Gas6. Samples also
included Gas6 together with warfarin, which blocks the
vitamin K-dependent g-carboxylation of the protein post-
translation (Korshunov, 2012) and therefore produces
Gas6 that is uncarboxylated and inactive, or the recom-
binant extracellular domain of Axl (Axl/Fc), which can
act as a ligand antagonist by quenching the ligand before
it binds to the receptor. After 3 days, optic nerves were
ﬁxed and whole mounted for confocal analysis and cell
counts. The results show that Gas6 signiﬁcantly increased
the number of Sox10-GFP positive cells, and this eﬀect
was blocked by both Axl/Fc and warfarin (Figure 3;
p< .001). These results were obtained from a number of
experiments performed on diﬀerent days, using separate
cultures from diﬀerent animals.
Gas6 Enhances Myelination Following
Lycolecithin-Induced Demyelination
in Organotypic Cerebellar Slice Cultures
Having observed that Gas6 promotes oligodendrogenesis
and myelination in the adult optic nerve, we next exam-
ined whether Gas6 could promotes remyelination after
toxic injury, using lysolecithin (LPC) to cause destruction
to the myelin in a cerebellar slice culture model, which
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Figure 1. Expression of TAM receptors and Gas6 in different mouse brain regions and at different postnatal ages. (a) qPCR expression
analysis of mRNA for Gas6 and TAM receptors. Values represent mean SEM of relative gene expression; n¼ 4 for all samples except
(continued)
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also features spontaneous repair (Birgbauer et al., 2004;
Zhang et al., 2011). Cerebellar slices were obtained from
mice aged between P8 and P12 and cultured for 3 days to
allow myelin formation to occur prior to adding LPC for
24 h, in normal medium or medium containing Gas6, fol-
lowed by a further 3 days culture following LPC removal.
Myelin loss was observed in slices treated with LPC,
whereas demyelination was signiﬁcantly decreased by
approximately twofold in slice cultures coincubated
with Gas6 (Figure 4; p< .05).
Gas6 Activates STAT3 Signaling
and Myelination in Optic Nerves
The JAK/STAT signaling pathway is a primary target of
Gas6 signaling (Yanagita et al., 2001) and has been
shown to promote oligodendrocyte regeneration and
remyelination (Hesp et al., 2015), as well as being a pro-
mising therapeutic target in multiple animal models of
MS (Liu et al., 2014). Therefore, we used Western blot
to determine STAT3 activation through detecting levels
of phosphorylated STAT3 (p-STAT3; Figure 5(a)) as well
as levels of MBP as a measure of diﬀerentiation or mye-
lination (Figure 5(b)). The protein extracts from cultured
adult optic nerves were analyzed, and Western blot band
intensities were quantiﬁed by densitometric analysis, nor-
malizing against GAPDH protein (Figure 5). The results
demonstrate that compared with controls, Gas6 stimula-
tion (400 ng/ml) resulted in a signiﬁcant increases in p-
STAT3 protein (Figure 5(a); p< .01) as well as MBP,
which was increased approximately twofold (Figure
5(b); p< .05). The results demonstrate that Gas6 activates
STAT3 signaling and stimulates the molecular process of
diﬀerentiation or myelination in the adult optic nerve.
Figure 1. Continued
for optic nerve (n¼ 3) and P14 cerebellum (n¼ 2). All samples were normalized against Cdc40 as internal control; *p< .05, **p< .01,
***p< .001, ****p< .0001 for comparisons as indicated. Columns containing letter a are significant compared with cortex of the same age,
and columns containing letter b are significant compared with cerebellum of the same age. (b) Representative Western blot of Axl, Tyro3,
and GAPDH (loading control) proteins. Lanes correspond to the following: (1) P7 cortex, (2) P7 cerebellum, (3) P14 cortex, (4) P14
cerebellum, (5) adult cortex, (6) adult cerebellum, and (7) adult optic nerve. The histograms show the quantification of Axl and Tyro3
protein expression by densitometric analysis. Values represent mean SEM (n¼ 4 blots); *p< .05, #p¼ .056 between samples as indicated
by lines. Columns containing letter a are significant compared with cortex of the same age, and columns containing letter b are significant
compared with cerebellum of the same age.
Figure 2. Expression of Tyro3, Axl, and Gas6 mRNA in human glial cell cultures. Extracted mRNA from human astrocytes and human
oligodendrocyte precursors were analyzed by qPCR using specific primers for human Tyro3, Axl, and Gas6 genes. Results were analyzed
based on 2Ct method.
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Gas6 Stimulates STAT3 Phosphorylation
in Mature Oligodendrocytes and Astrocytes
Having observed by Western blot that Gas6 stimulates
STAT3 phosphorylation in cultured optic nerves, we then
investigated the speciﬁc cell types in which this STAT3
activation occurred, through confocal microscopic ana-
lysis of cerebellar slice cultures. After 3 h culture incuba-
tion in the presence of Gas6, ﬁxed cerebellar sections were
double stained with p-STAT3 antibody together with
antibodies for mature oligodendrocyte, astrocyte, and
neuronal markers. The double immunostaining of
Gas6-treated tissues showed p-STAT3 to be present pre-
dominantly in mature oligodendrocytes and also in some
astrocytes but not in neurons (Figure 6(a) and
Supplementary Figure S3). Our data indicate that treat-
ment of cerebellar slices with Gas6 for only 3 h is enough
for activating STAT3, and thus the eﬀect of Gas6 on
increased level of STAT3 phosphorylation is not due to
increased level of STAT3 protein, which is a longer term
process.
Having observed that oligodendrocytes express Tyro3,
we attempted to determine whether Tyro3 was the TAM
receptor that mediated the observed eﬀects of Gas6. For
this, we performed Western blots to investigate levels of
phosphorylated (activated) Tyro3 (p-Tyro3) in cultured
mouse optic nerves treated with Gas6 for 3 h. The
Western blotting shows that compared with control,
Gas6 stimulated a signiﬁcant increase in p-Tyro3 protein
levels in optic nerves, showing that Gas6 directly activates
Tyro3 in the white matter (Figure 6(b)). The apparent
discrepancy between the molecular weight of total
Tyro3 (140 kDa) and p-Tyro3 (100 kDa) is due to
the respective antibodies binding to diﬀerent forms of
Tyro3. The anti-Tyro3 antibody is highly selective for
the fully mature Tyro3, whereas the anti-p-Tyro3 recog-
nizes the smaller band species of Tyro3. We also per-
formed these experiments in the presence of a speciﬁc
Figure 3. Effect of Gas6 on number of OPCs or oligodendrocytes in cultured mouse optic nerves. (a) Confocal images of optic nerves
treated with mock medium (Gas6) and Gas6, showing Sox10þ cells with green fluorescence. (b) Cell counts from images taken from
optic nerves treated with Gas6 in the absence or presence of two Gas6 antagonists: soluble Axl receptor (Axl/Fc) and Warfarin-Gas6.
Values represent mean SEM (control and Gas6, n¼ 8; Axl/FcþGas6, n¼ 2; Warfarin-Gas6, n¼ 4; n represents number of separate
experiments); ***p< .001 versus control (SEM values are as follows: Mock¼ 5.0648, Gas6¼ 3.5669, Axl/FcþGas6¼ 4.0488, Warfarin-
Gas6¼ 3.4071, analysis of variance with Bonferroni correction).
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small molecule inhibitor of Axl and BGB324
(Barcena et al., 2015; Vouri et al., 2015) and observed
that blocking Axl did not aﬀect the Gas6 eﬀect on mye-
lination, further indicating that the myelination eﬀect
occurs speciﬁcally via Tyro3 receptor (Supplementary
Figure S1).
Gas6 Alters MS-Related Gene Expression in
Cultured Optic Nerves in a Promyelinating Direction
The eﬀect of Gas6 on expression of 84 diﬀerent MS-
related genes was examined in the adult optic nerve,
using the Mouse Multiple Sclerosis PCR array
(Qiagen). Fifteen genes were identiﬁed as being signiﬁ-
cantly altered by Gas6 treatment compared with controls
(Table 1), seven being upregulated twofold and eight
downregulated twofold. Among those, some of
the altered genes were selected for further individual
analysis by qPCR, including the genes for matrix
metalloproteinase-9 (MMP9), which is able to mediate
blood–brain barrier (BBB) injury (Ravindran et al.,
2011), the astrocyte marker GFAP (Scheller and
Kirchhoﬀ, 2009), and Epha1, which is an RTK
(Owshalimpur and Kelley, 1999). The individual follow-
up qPCR analyses conﬁrmed that MMP9, Gfap, and
Epha1 genes were all signiﬁcantly downregulated in the
optic nerve following Gas6 treatment (Figure 7).
Discussion
The three homologous TAM receptors and their common
ligand Gas6 are expressed widely throughout the body
(Haﬁzi and Dahlba¨ck, 2006a, 2006b). However, their
expression proﬁles in the CNS, and their functional
roles therein, remain to be comprehensively character-
ized. In the present study, we show that Gas6 and all
three TAM receptors are expressed in the mouse brain
at mRNA level, as well as Tyro3 and Axl protein, and
Figure 4. Gas6 significantly attenuates demyelination in a toxin-induced demyelination model. (a) Cerebellar slice cultures were treated
with vehicle (methanol), LPCþMock medium (Gas6), and LPCþGas6 and stained with MBP antibody. For each treatment within an
experiment, one cerebellar slice was used, and one field of view per slice was analyzed. Images were taken from the top end of the lobules
were the axons spread out. Scale bar¼ 50mm. (b) Quantification of myelination through the number of MBPþ axons with lengths greater
than 50 mm. Values represent mean SEM (n¼ 6 experiments); *p< .05 for comparison indicated, analysis of variance with Bonferroni
correction.
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that their expression increases during myelination and is
highest in the adult cortex. In addition, we show that
Gas6 promotes the generation of oligodendrocytes and
myelin in the white matter of the adult mouse optic
nerve and also attenuates myelin loss in the lysolecithin
model of demyelination in cerebellar slice cultures.
Furthermore, analysis of the molecular mechanisms of
action of Gas6 demonstrates that it activates the Tyro3
receptor, intracellular STAT3 signaling, and the pro-
gramming of a host of MS-related genes in a prorepair
and myelinating direction. These results therefore indi-
cate that Gas6 or TAM signaling is a potential target
for stimulating repair mechanisms that are relevant to
demyelination and MS.
All three TAM receptors were observed to be
expressed throughout the brain tissue, although Tyro3
was expressed in more regions and at higher levels com-
pared with Axl and Mer. This supports previous indica-
tions that Tyro3 is the primary TAM receptor mediating
the actions of Gas6 in the CNS (Prieto et al., 2000). In
addition, our data show that Tyro3 expression increases
during development in the CNS. These observations are
in line with previous time-course expression data, show-
ing Tyro3 protein to be very low at embryonic stages
while its expression begins to increase shortly after
birth, dramatically increasing between postnatal days
P3 and P15, reaching its peak level at P24, and remaining
at that level thereafter in the adult (Prieto et al., 2000).
Although most myelination occurs early in life, myelin-
ation carries on at least into late adolescence and, in some
regions of the CNS, may increase throughout much of
adult life (Emery, 2010). Therefore, the concomitant tem-
poral proﬁles of myelination and Tyro3 expression in the
developing mouse CNS suggest that Tyro3 plays a role in
oligodendrocyte development or maturation and myelin-
ation. In the Axl blot, a double band was observed at
both 120 kDa and 140 kDa, which are the well-known
alternately glycosylated versions of Axl (the 140 kDa pro-
tein being most mature; O’Bryan et al., 1995). Our results
showed clear expression of Axl protein in all brain
regions and ages analyzed, with no signiﬁcant diﬀerences
in levels of expression among them.
Figure 5. Effect of Gas6 on activation of intracellular STAT3 and myelination through MBP expression in cultured optic nerves.
Representative Western blots are shown of proteins (a) pSTAT3 and (b) MBP in optic nerve lysates. The graphs accompanying each blot
show the densitometric quantification of protein levels relative to GAPDH protein in those samples. Values represent mean SEM (n¼ 6
blots); *p< .05, **p< .01 versus control, Student t test. Gas6 significantly increased the phosphorylation of STAT3 as well as MBP in optic
nerve cultures.
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We also conducted qPCR analysis for Tyro3, Axl, and
Gas6 genes in separate pure cultures of human OPCs and
astrocytes. Tyro3 was highly expressed in oligodendro-
cytes, in which Axl expression was absent. This key ﬁnd-
ing therefore suggests that Gas6 acts directly on OPCs or
oligodendrocytes via the Tyro3 receptor to aﬀect their
fate and function. In contrast, Tyro3 expression was
lower in astrocytes compared with oligodendrocytes but
instead astrocytes showed a high level of Gas6 expres-
sion. This therefore suggests an indirect and supportive
role for astrocytes in regulating the fate and function of
oligodendrocytes, by providing the ligand through para-
crine signaling. However, this interpretation of relative
TAM expression comes with a certain degree of caution
as the human isolated glial cell cultures were not only
from diﬀerent brain regions but were also derived from
diﬀerent brains and at diﬀerent ages. Nevertheless, within
a speciﬁc cell type, our data clearly show that Tyro3 is
present in oligodendrocytes, while Axl is virtually absent
in these cells. Furthermore, according to Figure 1(a), Mer
mRNA was also observed in the CNS, although we did
not characterize its expression pattern in glial cells, but
according to previous reports, it is mainly expressed in
microglia within the CNS and is involved in phagocytic
Figure 6. Gas6 activates STAT3 in mature oligodendrocytes and astrocytes and activates Tyro3 receptor after 3 h stimulation in culture.
(a) Cerebellar slices were treated with mock or Gas6 medium for 3 h, and fixed sections were double stained for p-STAT3 and APC
(mature oligodendrocyte marker), p-STAT3 and GFAP (astrocyte marker), p-STAT3 and NeuN (neuronal marker; scale bar¼ 20mm). The
stainings reveal that p-STAT3 is present in oligodendrocytes and astrocytes but not in neurons. The arrows point to cells that are both
GFAPþ and p-STAT3þ. (b) Representative Western blot of p-Tyro3 protein in optic nerve lysate. The graph shows the densitometric
quantification of protein level relative to actin in the same sample. Values represent mean SEM (n¼ 5 blots); **p< .01 versus control,
Student t test. Gas6 significantly increased the activation of Tyro3.
Table 1. Summary of Genes in Cultured Mouse Optic Nerves





Gas6 Mock Ct 2Ct
Ccl3 3.06 4.18 1.12 2.173469725
Ccl7 0.45 1.62 1.17 2.250116969
Cxcl11 8.86 10.31 1.45 2.732080514
Fasl 11.71 13.39 1.68 3.20427951
H2-Eb1 12.12 14.07 1.95 3.863745316
Il13 11.82 13.29 1.47 2.770218936
Il1b 8.65 9.69 1.04 2.056227653
Ednra 8.08 6.65 1.43 0.371131
Epha1 9.36 8.06 1.3 0.406126198
GFAP 1.06 0.38 1.44 0.368567304
Mag 2.09 0.79 1.3 0.406126198
MMP9 6.43 5.41 1.02 0.493116352
Nr2f1 7.27 5.47 1.8 0.287174589
Tubb4 3.04 2.01 1.03 0.489710149
Vcam1 2.5 1.3 1.2 0.435275282
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activity of these cells (Fourgeaud et al., 2016). Axl has
also been reported to be present in microglia, and no
Tyro3 was observed in these cells (Fourgeaud et al.,
2016). Also, it was shown that, in addition to Mer, Axl
is also essential for the phagocytic activity and nonin-
ﬂammatory properties of microglia cells, including
removal of cell debris (Fourgeaud et al., 2016).
Moreover, as we have only analyzed glial cells in this
study, it is important to note that expression of Gas6
expression has been reported in diﬀerent neuronal cells
including Purkinje neurons, motor neurons of spinal
cord, as well as large dorsal root ganglia neurons (Li
et al., 1996; Prieto et al., 1999). Therefore, it is also pos-
sible that neurons may play a similar supportive role in
regulating oligodendrocyte development and function, as
astrocytes do.
As well as in the brain, qPCR analysis of adult mouse
optic nerve demonstrated that Gas6 or TAM signaling
components are also present in this tissue, with relative
levels of expression indicated in the following order
Tyro3>Axl>Mer. Also, Gas6 stimulation of optic
nerve from Sox10-EGFP mice further conﬁrmed the pres-
ence and activity of TAM receptors in CNS white matter,
through which they promote the generation of oligo-
dendrocyte lineage cells. The Sox10-EGFP reporter iden-
tiﬁes both oligodendrocytes and OPCs, since Sox10
marks all stages of oligodendrocyte development (Stolt
et al., 2006); but in the adult, OPCs are continuously
generating new oligodendrocytes and are the likely tar-
gets of Gas6 in our study (Gonzalez-Pereza and Alvarez-
Buyllab, 2011). In addition to oligodendrogenesis, Gas6
stimulated increases the levels of MBP protein in the
adult optic nerve, which indicates that Gas6 also pro-
motes myelination in mature oligodendrocytes (Mi
et al., 2011). Therefore, these observations together dem-
onstrate that Gas6 boosts both the number of OPCs as
well as mature myelinating oligodendrocytes. In this
regard, it is worthwhile considering protein S, a protein
homologous to Gas6 that is also a TAM receptor ligand.
However, its expression appears restricted in the CNS,
with low levels of protein S mRNA observed in locus
coeruleus and high levels of mRNA in the choroid
plexus (Prieto et al., 1999). Furthermore, the expression
of protein S appears to be primarily neuronal, having
been detected in the cortex, hippocampal pyramidal neu-
rons, and granule neurons of the dentate gyrus of the
rabbit brain (He et al., 1995; Prieto et al., 2007).
Gas6 stimulation also led to a decreased demyelination
in a cerebellar slice culture model of demyelination by
lysolecithin (Birgbauer et al., 2004), which is one of the
most commonly used toxins to induce focal demyelin-
ation in diﬀerent parts of the brain (van der Star et al.,
2012). Our results show that treatment with Gas6 signiﬁ-
cantly attenuated the extent of demyelination that con-
tinues for days after exposure to lysolecithin (Birgbauer
et al., 2004). This is consistent with studies in the cupri-
zone model of demyelination, which showed systemic
administration of Gas6 to enhance remyelination
(Tsiperson et al., 2010), while Gas6 ablation decreased
the number of myelinating oligodendrocytes and delayed
recovery (Binder et al., 2011). Together, these studies
demonstrate that Gas6 or TAM signaling plays a major
role in oligodendrocyte generation and myelination in the
adult CNS. However, our experiment was focused on
the protective eﬀect of Gas6 during demyelinating
injury, whereas it is also important to investigate the
acceleratory eﬀect of Gas6 on remyelination after
damage. Thus far, we did not observe an enhanced
remyelination when Gas6 was added 3 days after LPC
damage (Supplementary Figure S2). However, further
detailed time-course studies are warranted to explore
the time window during which Gas6 can be eﬀective as
an enhancer of remyelination post damage. Furthermore,
although Gas6 increases MBP and blocks demyelination
in culture, it is also worthwhile to measure the axon
diameter or g-ratio by electron microscopy to determine
speciﬁcally the location of myelination as being around
axons, and hence contributing to increased axon thick-
ness. Also, although this study was focused on the non-
microglial response to Gas6, it is nevertheless possible,
considering the phagocytosis-mediating role of Mer
(Chen et al., 1997), that Gas6 could also activate Mer
in microglia in our culture model; this requires further
investigation.
In addition to the ligand Gas6, the role of Axl receptor
has also investigated by other research groups in demye-
lination models. In a study using the cuprizone model of
Figure 7. Effect of Gas6 on expression of selected MS-related
genes in cultured mouse optic nerves. qRT-PCR was performed on
extracts from mock and Gas6-treated optic nerve cultures, using
specific primer or probe sets, and normalizing expression against
the GAPDH gene. Treatment of optic nerves with Gas6 resulted in
downregulation of Epha1, GFAP, and MMP9 genes. Values represent
mean SEM (n¼ 4 for qPCR experiments for all genes except for
Epha1 (n¼ 2)).
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demyelination, Axl knockout mice showed no signiﬁcant
diﬀerences to wild-type mice in axon diameter, myelin
thickness, and g-ratio of myelin-containing axons
(Hoehn et al., 2008). This therefore suggests that Axl is
not the main receptor involved in remyelination or that
loss of signaling through all three TAM receptors is more
harmful than loss of signaling through a single TAM
receptor. This is consistent with our observations,
which point toward the prominence of Tyro3 in oligo-
dendrocyte biology and myelination, reinforced by its
unique mRNA expression in oligodendrocytes.
As our expression analysis indicated Tyro3 as the most
prominent TAM receptor in the CNS, at least as concerns
oligodendrocytes, we therefore hypothesized that the Gas6
eﬀects on OPC proliferation, oligodendrocyte maturation,
and myelination are likely occurring via a direct activation
of Tyro3 in these cell populations. We therefore utilized
our optic nerve culture model to also investigate the rela-
tively acute activation of Tyro3 in response to Gas6 stimu-
lation. Thus, Gas6 stimulated a higher activation state of
Tyro3 after 3 h in the optic nerve, as observed by increased
p-Tyro3 protein levels. This observation is supported by a
recent study in the peripheral nervous system that showed
Tyro3 to be an important modulator of myelination by
Schwann cells (Miyamoto et al., 2015).
We also observed that the transcriptional regulator
protein STAT3 was mobilized by Gas6 stimulation
using both of our in vitro culture models. Gas6 increased
levels of phosphorylated STAT3 protein in the optic
nerve, and using the slices for microscopy, we were able
to localize the pSTAT3 to oligodendrocytes as well as to a
lesser extent astrocytes. Gas6 has previously been
reported to act via STAT3 to promote proliferation of
mesangial cells (Yanagita et al., 2001). This is consistent
with our current observations of Gas6-induced activation
of STAT3 and proliferation of OPCs or oligodendrocyte
in the optic nerve. STAT3 controls a large number of
genes that are involved in apoptosis, cell migration, cell
cycle regulation, and angiogenesis as well as modulation
of immune suppressive factors (Ferguson et al., 2015).
Once STAT3 becomes activated via phosphorylation, it
translocates to the nucleus and binds to speciﬁc DNA
sequences to activate the expression of target genes that
regulate proliferation and diﬀerentiation (Qi and Yang,
2014). There is also evidence that shows STAT3 activa-
tion is potentially important during neuroinﬂammation
by protecting myelin development (Nobuta et al., 2012).
Although neurons also express Tyro3 (Schulz et al.,
1995), we found Gas6 to induce STAT3 activation pre-
dominantly in OPCs or oligodendrocytes, as would be
expected for diﬀerentiating or proliferating cells
(Fukada et al., 1996). Therefore, STAT3 appears to be
a key intracellular mediator of Gas6 signaling in oligo-
dendrocytes, most likely via Tyro3, to aﬀect their devel-
opment and the subsequent myelination of axons.
From a mini-array screen, we also observed Gas6 to
induce signiﬁcant changes in expression of multiple genes
relevant to glial biology and MS in the cultured optic
nerve, including downregulation of MMP9, Epha1, and
GFAP genes. GFAP is an astrocyte-speciﬁc protein and is
used as a marker of reactive astrogliosis (Beckerman
et al., 2015), suggesting that Gas6 may modulate astro-
glial responses in the optic nerve. MMP9 is a proteolytic
enzyme that degrades type IV collagen, laminin, and
ﬁbronectin, all of which are major components of the
basement membrane of the BBB (Zheng et al., 2014).
During a relapse course of MS, active B cells increase
the expression and secretion of MMP9 protein, ultimately
resulting in digestion of myelin as well as neurological
disability (Aung et al., 2015). Furthermore, it has been
shown that MMP9 can be secreted by OPCs that have
proliferated at sites of demyelination in the CNS, which
results in opening of the BBB and the subsequent second-
ary cascades of cerebrovascular injury and demyelination
(Seo et al., 2013). Moreover, disruption of the BBB has
been considered as one of the initial steps in the develop-
ment of disease in MS patients (Alvarez et al., 2011).
Also, the role of MMP9, at least produced by active B
lymphocytes, in the disruption of the BBB and degrad-
ation of MBP protein is well recognized (Aung et al.,
2015). Thus, our observation of Gas6 causing a twofold
downregulation of the MMP9 gene suggests that Gas6
may help maintain BBB integrity and hence inhibit
immune cell inﬁltration into the CNS during the course
of MS; this is a focus of investigation in subsequent
studies.
In conclusion, this study shows that components of
Gas6 or TAM signaling are present throughout the
adult CNS, and that, speciﬁcally, Tyro3 is present on
OPCs or oligodendrocytes and mediates their develop-
ment and function in response to the ligand Gas6, while
astrocytes are the main source of the Gas6. Gas6 pro-
motes the development and maturation of oligodendro-
cytes from OPCs and myelination in the adult CNS, as
well as stimulating remyelination after toxic injury by
lysolecithin. In addition, we show that the eﬀects of
Gas6 involve regulation of a set of genes that, through
their coordinated upregulation or suppression, push the
glial cell developmental pathway in a promyelinating dir-
ection. These results support a prominent role for Gas6 in
promoting CNS repair after demyelination, and thus an
attractive consideration for novel therapeutic approaches
for MS.
Summary
We detected regional and age-dependent expression of
TAM family receptors in the mouse CNS. Their
common ligand Gas6 boosted mature oligodendrocyte
numbers, stimulated myelination, and dampened toxin-
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induced demyelination. Gas6 acted via Tyro3 receptor to
activate intracellular STAT3 signaling in oligodendrocytes.
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